U.S. Pharma Stock News

Navan (NAVN) has been drawing attention after a sharp pullback, with the stock down about 20% over the past month and close to 39% over the past 3 months. See our latest analysis for Navan. The recent weakness, including a 7.69% 1 day share price return and a 45.35% year to date share price return, suggests momentum has been fading despite interest in Navan's AI powered travel and expense platform and its latest close at $8.88. If sharp moves in a single name feel uncomfortable, you can...

If you are wondering whether Envista Holdings is attractively priced right now, this article will walk through what the current share price might be implying about its value. The stock last closed at US$25.44, with a 56.6% return over the past year, a 17.3% gain year to date, but declines of 8.9% over 7 days and 15.7% over 30 days that may have shifted how investors think about its risk and reward. Recent news flow around Envista has focused on its position in the healthcare space and how...

Advance Auto Parts (AAP) is back on investors’ radar after management reported a return to positive comparable sales and operating income profitability, following extensive turnaround work across its supply chain, merchandising, and store operations. See our latest analysis for Advance Auto Parts. The recent turnaround update and conference commentary come after a volatile few years. The share price is at US$52.66 with a 90 day share price return of 13.56% and a 1 year total shareholder...

Hillman Solutions recently reported a softer quarter, with revenue growing 4.5% year on year but falling short of analyst expectations and issuing full-year revenue guidance that also trailed consensus. Despite lifting its full-year outlook more than peers, Hillman’s results were viewed unfavorably, highlighting how even incremental misses against expectations can weigh on sentiment around its professional tools and hardware business. Next, we’ll examine how this earnings miss and cautious...

Iridium Communications Inc. has affirmed a quarterly dividend of US$0.1500 per share, payable on March 31, 2026, to shareholders of record and ex-dividend on March 16, 2026. This dividend affirmation, following a quarter where earnings per share exceeded analyst expectations despite flat revenue, underscores management’s commitment to ongoing cash returns. We’ll now examine how the sustained dividend alongside better-than-expected earnings shapes Iridium’s investment narrative and future...

What recent performance says about Ingersoll Rand (IR) Ingersoll Rand (IR) has recently seen mixed share performance, with a 4.7% decline over the past day, a 10.3% decline over the past week, and a 17.0% decline over the past month. Even with that pressure, the stock shows a small 0.7% decline over the past 3 months. Longer windows are positive, including a 1.8% total return over the past year and higher multi year returns. See our latest analysis for Ingersoll Rand. Recent selling pressure...

IonQ (NYSE:IONQ) is providing quantum key distribution technology for Romania’s National Quantum Communication Infrastructure, RoNaQCI, aimed at securing critical European communications. The company announced a US$1.8b acquisition of SkyWater Technology, creating what it describes as the industry's first vertically integrated quantum company. These developments expand IonQ’s role in European secure communications and bring chip manufacturing capabilities in house. IonQ, a pure play quantum...

On March 11, 2026, AIRO Group Holdings, Inc. presented at the Cantor Global Technology & Industrial Growth Conference in New York, with Executive Chairman Chirinjeev Kathuria, CEO Joe Burns, and CFO Mariya Pylypiv outlining the company’s integrated aerospace and defense offering. The focus on defense-oriented drones, proprietary technology and vertically integrated manufacturing, together with R&D and government certifications, underscored AIRO’s effort to build recurring revenue across...

ICU Medical, NasdaqGS:ICUI, is dealing with ongoing revenue stagnation and rising capital intensity that point to operational and market pressures. Future sales are projected to decline, alongside shrinking free cash flow margins, highlighting concerns about the company’s ability to convert revenue into cash. These developments are emerging as fresh issues for investors and other stakeholders who follow ICU Medical’s financial and competitive position. ICU Medical’s current share price of...

If you are wondering whether Akamai Technologies is fairly priced or if the recent buzz has left it mispriced, you are in the right place for a closer look at what the current share price might be implying. Akamai's share price closed at US$105.47, with returns of 4.4% over 7 days, 11.7% over 30 days, 23.9% year to date, 34.1% over 1 year and 45.4% over 3 years, while the 5 year return stands at 7.4%. These price moves sit against an ongoing focus on Akamai's role in content delivery and...

Recent analysis highlighted that CorVel passed a high-quality investment screen, underpinned by very large returns on invested capital and a debt-free balance sheet in its cost containment and claims management business. This focus on financial strength and operational resilience has drawn attention from investors who prioritize durable business models and conservative balance sheets. Next, we’ll examine how CorVel’s debt-free position shapes its investment narrative in light of the latest...

Wave Life Sciences (WVE) drew investor attention after reporting interim Phase I data for its INHBE obesity candidate WVE-007, and detailing a cash position it expects to fund multiple trials and regulatory milestones through 2026. See our latest analysis for Wave Life Sciences. The latest WVE-007 readout and funding runway arrive after a 1-year total shareholder return of about 30% and a very large 3-year total shareholder return, even as the 90-day share price return of a 19.38% decline and...

Playtika Holding (NasdaqGS:PLTK) announced that Chief Financial Officer and President Craig Abrahams will resign effective April 1, 2026. Tae Lee, who has corporate finance experience at Playtika and Meta, will become acting CFO when the change takes effect. Board Chairperson Robert Antokol will also assume the role of President, taking on an expanded leadership position. Playtika operates in the mobile gaming sector, where user engagement, live operations and content updates tend to matter...

RLX Technology Inc. has reported its full-year 2025 results, with revenue of CNY 3,958.86 million and net income of CNY 921.87 million, alongside higher basic and diluted earnings per share from continuing operations compared with 2024. Over the course of its CNY 330 million share repurchase program completed in 2025, RLX bought back 12.71% of its shares, meaning recent profit growth is now spread across a meaningfully smaller share count. With full-year earnings rising and a sizeable...

Integer Holdings event overview Integer Holdings (ITGR) has drawn fresh attention after recent share price moves, with the stock down about 3% over the past month and up roughly 15% in the past 3 months. See our latest analysis for Integer Holdings. The 1-year total shareholder return decline of 29.65% contrasts with the recent 14.55% 90-day share price return. This suggests momentum has picked up after a weaker stretch for long-term holders at the latest share price of US$83.30. If Integer’s...

Fluor (NYSE:FLR) is opening a new office in Bucharest, Romania to support advanced nuclear energy projects in Eastern Europe. The office will focus on major Romanian projects, including the Doicești small modular reactor installation and the expansion of the Cernavodă nuclear power plant. This move reflects Fluor’s broader push into European nuclear infrastructure and clean energy solutions. For you as an investor, the Bucharest office highlights how Fluor is positioning its engineering and...

BridgeBio Pharma recently presented additional positive interim data from its Phase 3 FORTIFY trial of oral BBP-418 in LGMD2I/R9, showing broad efficacy across mobility, biomarker, and subgroup endpoints, along with a safety profile comparable to placebo. These results underpin BridgeBio’s plan to file for US FDA approval in the first half of 2026, positioning BBP-418 as a potential first-ever approved therapy for any form of limb-girdle muscular dystrophy and highlighting the company’s...

Merchants Bancorp recently reported quarterly results that exceeded analyst expectations for revenue, earnings per share and net interest income, highlighting continued strength in its low-risk, government-backed lending programs such as multi-family mortgage banking and mortgage warehousing. This earnings beat underscores how the bank’s focus on government-supported credit channels can support business resilience even when broader financial conditions are uncertain. Next, we will examine...

Netskope (NTSK) sets the stage with FY 2026 numbers Netskope (NTSK) has just put fresh FY 2026 figures on the table, with fourth quarter revenue at US$196.3 million and a basic EPS loss of US$0.14, alongside a full year basic EPS loss of US$3.18 on trailing twelve month revenue of US$709.0 million. Over recent quarters the company has seen revenue move from US$148.5 million in Q4 FY 2025 to US$196.3 million in Q4 FY 2026, while quarterly basic EPS has ranged from a loss of US$0.72 to a loss...

What is driving interest in U.S. Bancorp stock right now? U.S. Bancorp (USB) is back in focus after Q4 results that slightly topped revenue expectations but missed tangible book value per share estimates, alongside fresh dividend declarations and visible shifts in institutional ownership. See our latest analysis for U.S. Bancorp. The latest sell off has taken U.S. Bancorp’s share price to US$51.48, with a 1 month share price return of negative 14.98% and a year to date share price return of...

Kosmos Energy (KOS) has completed a large follow-on equity offering of 97,500,000 common shares at US$1.90, raising about US$185.25 million to repay commercial debt and other outstanding borrowings. See our latest analysis for Kosmos Energy. The follow on offering sits against a sharp rebound in Kosmos Energy’s 90 day share price return of 123.53% and year to date share price return of 155.38%. However, the 3 year total shareholder return is a 64.21% loss, suggesting recent momentum has...

DTE Energy disclosed in a recent SEC filing that President and CEO Joi Harris received an estimated US$8,457,065 in 2025 compensation, up very large from 2024, while several major institutional investors, including Capital World Investors and Capital International Inc. CA, increased their stakes in the company over the third quarter of 2025. This combination of higher leadership pay and rising institutional ownership highlights how large investors and the board are responding to DTE’s...

Unusual Machines (UMAC) is back in focus after its latest earnings report, which showed full year 2025 sales of US$11.2 million, a net loss of US$19.2 million, and a reduced basic loss per share. See our latest analysis for Unusual Machines. The stock has reacted strongly around these updates, with a 1 day share price return of 11.64% and a 30 day share price return of 75.79%. This has contributed to a very large 1 year total shareholder return of 291.34%, which suggests momentum has been...

If you are wondering whether LKQ's recent share price weakness has left the stock looking mispriced, this breakdown will help you weigh what you are paying against what you are getting. The shares recently closed at US$29.75, with returns of a 5.4% decline over 7 days, a 14.0% decline over 30 days, a 0.9% decline year to date and a 25.2% decline over 1 year, alongside a 40.6% decline over 3 years and a 23.2% decline over 5 years. Recent coverage around LKQ has focused on its position as a...